Search research articles
Contact Us
Filters
Showing results (71-80 of 101) with videos related to
Page
of 11
Sort By:
Cancer
|
February 23, 2022
RESILIENT part 1: a phase 2 dose-exploration and dose-expansion study of second-line liposomal irinotecan in adults with small cell lung cancer
Luis Paz-Ares, David R Spigel, Yuanbin Chen, et al.
Molecular Oncology
|
February 28, 2023
Dynamic changes in circulating tumor DNA assessed by shallow whole-genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC
Caterina Carbonell, Joan Frigola, Nuria Pardo, et al.
Peerj
|
December 17, 2025
Revisiting the Poison Dart Frog <i>Ameerega ingeri</i> (Anura: Dendrobatidae): external morphology, tadpoles, natural history, distribution, advertisement call, phylogenetic position and conservation
Juan C Diaz-Ricaurte, Alejandro Navarro-Morales, César Malambo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 9, 2024
Reply to P. de Boissieu et al
David R Spigel, Afshin Dowlati, Yuanbin Chen, et al.
Translational Lung Cancer Research
|
October 24, 2025
Multimodal prehabilitation to prevent loss of cardiorespiratory fitness in patients with locally advanced lung cancer undergoing chemoimmunotherapy: protocol for a non-randomized multicentre study
Yu Xiao Chen, Raquel Sebio-Garcia, Maria Jose Arguis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2024
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer
David R Spigel, Afshin Dowlati, Yuanbin Chen, et al.
Nature Communications
|
May 8, 2024
A quantitative gibberellin signaling biosensor reveals a role for gibberellins in internode specification at the shoot apical meristem
Bihai Shi, Amelia Felipo-Benavent, Guillaume Cerutti, et al.
Molecular Oncology
|
December 20, 2020
Molecular profiling of long-term responders to immune checkpoint inhibitors in advanced non-small cell lung cancer
Joan Frigola, Alejandro Navarro, Caterina Carbonell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 1, 2026
Durvalumab Consolidation in Limited-Stage SCLC: Outcomes by Prior Concurrent Chemoradiotherapy and Prophylactic Cranial Irradiation in the Phase 3 ADRIATIC Trial
Suresh Senan, Byoung Chul Cho, Konstantin K Laktionov, et al.
Clinical Lung Cancer
|
March 10, 2025
Brief Report: Real-World Clinical Utility of Next-Generation Sequencing of Circulating Tumor DNA for Patients With Advanced Lung Squamous Cell Carcinoma (SQUIN)
Miguel García-Pardo, Marta García de Herreros, Juan Carlos Laguna, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 101) with videos related to
Sort By:
Page
of 11
Cancer
|
February 23, 2022
RESILIENT part 1: a phase 2 dose-exploration and dose-expansion study of second-line liposomal irinotecan in adults with small cell lung cancer
Luis Paz-Ares, David R Spigel, Yuanbin Chen, et al.
Molecular Oncology
|
February 28, 2023
Dynamic changes in circulating tumor DNA assessed by shallow whole-genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC
Caterina Carbonell, Joan Frigola, Nuria Pardo, et al.
Peerj
|
December 17, 2025
Revisiting the Poison Dart Frog <i>Ameerega ingeri</i> (Anura: Dendrobatidae): external morphology, tadpoles, natural history, distribution, advertisement call, phylogenetic position and conservation
Juan C Diaz-Ricaurte, Alejandro Navarro-Morales, César Malambo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 9, 2024
Reply to P. de Boissieu et al
David R Spigel, Afshin Dowlati, Yuanbin Chen, et al.
Translational Lung Cancer Research
|
October 24, 2025
Multimodal prehabilitation to prevent loss of cardiorespiratory fitness in patients with locally advanced lung cancer undergoing chemoimmunotherapy: protocol for a non-randomized multicentre study
Yu Xiao Chen, Raquel Sebio-Garcia, Maria Jose Arguis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2024
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer
David R Spigel, Afshin Dowlati, Yuanbin Chen, et al.
Nature Communications
|
May 8, 2024
A quantitative gibberellin signaling biosensor reveals a role for gibberellins in internode specification at the shoot apical meristem
Bihai Shi, Amelia Felipo-Benavent, Guillaume Cerutti, et al.
Molecular Oncology
|
December 20, 2020
Molecular profiling of long-term responders to immune checkpoint inhibitors in advanced non-small cell lung cancer
Joan Frigola, Alejandro Navarro, Caterina Carbonell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 1, 2026
Durvalumab Consolidation in Limited-Stage SCLC: Outcomes by Prior Concurrent Chemoradiotherapy and Prophylactic Cranial Irradiation in the Phase 3 ADRIATIC Trial
Suresh Senan, Byoung Chul Cho, Konstantin K Laktionov, et al.
Clinical Lung Cancer
|
March 10, 2025
Brief Report: Real-World Clinical Utility of Next-Generation Sequencing of Circulating Tumor DNA for Patients With Advanced Lung Squamous Cell Carcinoma (SQUIN)
Miguel García-Pardo, Marta García de Herreros, Juan Carlos Laguna, et al.
Page
of 11